Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?

Kuan-Teh Jeang

doi:10.18632/oncotarget.179

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Perspectives:

Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?

Kuan-Teh Jeang _

PDF | HTML | How to cite

Oncotarget. 2010; 1:453-456. https://doi.org/10.18632/oncotarget.179

Metrics: PDF 2717 views | HTML 3703 views | ?

Abstract

Received: August 5, 2010, Accepted: September 29, 2010, Published: October 1, 2010

The mechanism of HTLV-1 transformation of cells to Adult T cell leukemia (ATL) remains not fully understood. Currently, the viral Tax oncoprotein is known to be required to initiate transformation. Emerging evidence suggests that Tax is not needed to maintain the transformed ATL phenotype. Recent studies have shown that HTLV-1 transformed cells show deregulated expression of cellular microRNAs (miRNAs). Here we discuss the possibility that early ATL cells are Tax-oncogene-addicted while late ATL cells are oncogenic microRNA (oncomiR) – addicted. The potential utility of interrupting oncomiR addiction as a cancer treatment is broached.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 179

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Perspectives:

Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?

Abstract